The combination of ibrutinib and obinutuzumab in CLL
Why daratumumab is effective in multiple myeloma - results from the CASTOR trial
Choosing treatment options for CLL and combining novel drugs
An update on immunotherapy for multiple myeloma in 2016
Ignacio Melero Bermejo et al.
ASH 2014: The management of CLL